These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1546 related articles for article (PubMed ID: 28974553)

  • 1. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]).
    Bartolucci J; Verdugo FJ; González PL; Larrea RE; Abarzua E; Goset C; Rojo P; Palma I; Lamich R; Pedreros PA; Valdivia G; Lopez VM; Nazzal C; Alcayaga-Miranda F; Cuenca J; Brobeck MJ; Patel AN; Figueroa FE; Khoury M
    Circ Res; 2017 Oct; 121(10):1192-1204. PubMed ID: 28974553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of umbilical cord tissue-derived mesenchymal stem cells in the treatment of patients with aging frailty: a phase I/II randomized, double-blind, placebo-controlled study.
    Zhu Y; Huang C; Zheng L; Li Q; Ge J; Geng S; Zhai M; Chen X; Yuan H; Li Y; Jia W; Sun K; Li Y; Ye T; Zhao Z; Liu H; Liu Z; Jiang H
    Stem Cell Res Ther; 2024 Apr; 15(1):122. PubMed ID: 38679727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Umbilical Cord-Derived Mesenchymal Stromal Cells Improve Left Ventricular Function, Perfusion, and Remodeling in a Porcine Model of Chronic Myocardial Ischemia.
    Liu CB; Huang H; Sun P; Ma SZ; Liu AH; Xue J; Fu JH; Liang YQ; Liu B; Wu DY; Lü SH; Zhang XZ
    Stem Cells Transl Med; 2016 Aug; 5(8):1004-13. PubMed ID: 27334487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous Allogeneic Mesenchymal Stem Cells for Nonischemic Cardiomyopathy: Safety and Efficacy Results of a Phase II-A Randomized Trial.
    Butler J; Epstein SE; Greene SJ; Quyyumi AA; Sikora S; Kim RJ; Anderson AS; Wilcox JE; Tankovich NI; Lipinski MJ; Ko YA; Margulies KB; Cole RT; Skopicki HA; Gheorghiade M
    Circ Res; 2017 Jan; 120(2):332-340. PubMed ID: 27856497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Umbilical Cord-Derived Mesenchymal Stromal Cells (MSCs) for Knee Osteoarthritis: Repeated MSC Dosing Is Superior to a Single MSC Dose and to Hyaluronic Acid in a Controlled Randomized Phase I/II Trial.
    Matas J; Orrego M; Amenabar D; Infante C; Tapia-Limonchi R; Cadiz MI; Alcayaga-Miranda F; González PL; Muse E; Khoury M; Figueroa FE; Espinoza F
    Stem Cells Transl Med; 2019 Mar; 8(3):215-224. PubMed ID: 30592390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial.
    Lanzoni G; Linetsky E; Correa D; Messinger Cayetano S; Alvarez RA; Kouroupis D; Alvarez Gil A; Poggioli R; Ruiz P; Marttos AC; Hirani K; Bell CA; Kusack H; Rafkin L; Baidal D; Pastewski A; Gawri K; Leñero C; Mantero AMA; Metalonis SW; Wang X; Roque L; Masters B; Kenyon NS; Ginzburg E; Xu X; Tan J; Caplan AI; Glassberg MK; Alejandro R; Ricordi C
    Stem Cells Transl Med; 2021 May; 10(5):660-673. PubMed ID: 33400390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial).
    Mathiasen AB; Qayyum AA; Jørgensen E; Helqvist S; Fischer-Nielsen A; Kofoed KF; Haack-Sørensen M; Ekblond A; Kastrup J
    Eur Heart J; 2015 Jul; 36(27):1744-53. PubMed ID: 25926562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial).
    Mathiasen AB; Jørgensen E; Qayyum AA; Haack-Sørensen M; Ekblond A; Kastrup J
    Am Heart J; 2012 Sep; 164(3):285-91. PubMed ID: 22980293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potentials of umbilical cord-derived mesenchymal stromal cells for ischemic-type biliary lesions following liver transplantation.
    Zhang YC; Liu W; Fu BS; Wang GY; Li HB; Yi HM; Jiang N; Wang G; Zhang J; Yi SH; Li H; Zhang Q; Yang Y; Chen GH
    Cytotherapy; 2017 Feb; 19(2):194-199. PubMed ID: 27964826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial.
    Hare JM; Fishman JE; Gerstenblith G; DiFede Velazquez DL; Zambrano JP; Suncion VY; Tracy M; Ghersin E; Johnston PV; Brinker JA; Breton E; Davis-Sproul J; Schulman IH; Byrnes J; Mendizabal AM; Lowery MH; Rouy D; Altman P; Wong Po Foo C; Ruiz P; Amador A; Da Silva J; McNiece IK; Heldman AW; George R; Lardo A
    JAMA; 2012 Dec; 308(22):2369-79. PubMed ID: 23117550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial.
    Heldman AW; DiFede DL; Fishman JE; Zambrano JP; Trachtenberg BH; Karantalis V; Mushtaq M; Williams AR; Suncion VY; McNiece IK; Ghersin E; Soto V; Lopera G; Miki R; Willens H; Hendel R; Mitrani R; Pattany P; Feigenbaum G; Oskouei B; Byrnes J; Lowery MH; Sierra J; Pujol MV; Delgado C; Gonzalez PJ; Rodriguez JE; Bagno LL; Rouy D; Altman P; Foo CW; da Silva J; Anderson E; Schwarz R; Mendizabal A; Hare JM
    JAMA; 2014 Jan; 311(1):62-73. PubMed ID: 24247587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale and design of a randomized controlled trial of allogeneic mesenchymal stem cells in patients with nonischemic cardiomyopathy.
    Greene SJ; Epstein SE; Kim RJ; Quyyumi AA; Cole RT; Anderson AS; Wilcox JE; Skopicki HA; Sikora S; Verkh L; Tankovich NI; Gheorghiade M; Butler J
    J Cardiovasc Med (Hagerstown); 2017 Apr; 18(4):283-290. PubMed ID: 26479144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human umbilical cord-derived stem cell sheets improve left ventricular function in rat models of ischemic heart failure.
    Wu Y; Zhang H; Wang S; Li L; Wang R; Jiang S
    Eur J Pharmacol; 2022 Jun; 925():174994. PubMed ID: 35513020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of therapeutic effects of mesenchymal stem cells from umbilical cord and bone marrow in the treatment of type 1 diabetes.
    Zhang W; Ling Q; Wang B; Wang K; Pang J; Lu J; Bi Y; Zhu D
    Stem Cell Res Ther; 2022 Aug; 13(1):406. PubMed ID: 35941696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow-derived mesenchymal stromal cell treatment in patients with ischaemic heart failure: final 4-year follow-up of the MSC-HF trial.
    Mathiasen AB; Qayyum AA; Jørgensen E; Helqvist S; Kofoed KF; Haack-Sørensen M; Ekblond A; Kastrup J
    Eur J Heart Fail; 2020 May; 22(5):884-892. PubMed ID: 31863561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial.
    Shi L; Huang H; Lu X; Yan X; Jiang X; Xu R; Wang S; Zhang C; Yuan X; Xu Z; Huang L; Fu JL; Li Y; Zhang Y; Yao WQ; Liu T; Song J; Sun L; Yang F; Zhang X; Zhang B; Shi M; Meng F; Song Y; Yu Y; Wen J; Li Q; Mao Q; Maeurer M; Zumla A; Yao C; Xie WF; Wang FS
    Signal Transduct Target Ther; 2021 Feb; 6(1):58. PubMed ID: 33568628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of umbilical cord-derived mesenchymal stem cells in Chinese adults with type 2 diabetes: a single-center, double-blinded, randomized, placebo-controlled phase II trial.
    Zang L; Li Y; Hao H; Liu J; Cheng Y; Li B; Yin Y; Zhang Q; Gao F; Wang H; Gu S; Li J; Lin F; Zhu Y; Tian G; Chen Y; Gu W; Du J; Chen K; Guo Q; Yang G; Pei Y; Yan W; Wang X; Meng J; Zhang S; Ba J; Lyu Z; Dou J; Han W; Mu Y
    Stem Cell Res Ther; 2022 May; 13(1):180. PubMed ID: 35505375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of tissue factor expression and administration routes on thrombosis development induced by mesenchymal stem/stromal cell infusions: re-evaluating the dogma.
    Hoang VT; Le DS; Hoang DM; Phan TTK; Ngo LAT; Nguyen TK; Bui VA; Nguyen Thanh L
    Stem Cell Res Ther; 2024 Feb; 15(1):56. PubMed ID: 38414067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of umbilical cord mesenchymal stem cells and standard immunosuppressive regimen for pediatric patients with severe aplastic anemia.
    Lan Y; Liu F; Chang L; Liu L; Zhang Y; Yi M; Cai Y; Feng J; Han Z; Han Z; Zhu X
    BMC Pediatr; 2021 Feb; 21(1):102. PubMed ID: 33639900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic mesenchymal stem cells as induction therapy are safe and feasible in renal allografts: pilot results of a multicenter randomized controlled trial.
    Sun Q; Huang Z; Han F; Zhao M; Cao R; Zhao D; Hong L; Na N; Li H; Miao B; Hu J; Meng F; Peng Y; Sun Q
    J Transl Med; 2018 Mar; 16(1):52. PubMed ID: 29514693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 78.